Genomics Growth in Precision Medicine Software Market 2024 4 Key Players Syapse, Fabric Genomics
The “Precision Medicine Software Market: Focused Insights 2024-2029” explores the dynamics Genomics of a rapidly growing industry. Valued at USD 1.72 billion in 2023, the market is expected to grow…
OS Therapies Successfully Completes $6 Million Private Placement
OS Therapies Announces $6 Million Private Placement to Fund Clinical Development of OST-HER2 for Osteosarcoma and Other Cancer Indications OS Therapies, a clinical-stage biotechnology company focused on developing innovative cancer…
Cancer Immunotherapy Market 2025-2029: Groundbreaking Insights & Forecasts
The Future of Cancer Immunotherapy: Market Insights 2025-2029 The report titled “Cancer Immunotherapy Market 2025-2029 – Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant Guides”…
Kamal Adwan Hospital Tragically Forced to Close Amid 3 Escalating Raids and Relentless Attacks
The World Health Organization (WHO) has expressed deep dismay following the raid on Kamal Adwan Hospital, which has rendered the last major health facility in North Gaza non-operational. This attack…
WuXi Biologics and Sino Biopharm Forge Groundbreaking Deal for 5 Cutting-Edge Biologics Discovery
WuXi Biologics a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has entered a service agreement with Sino Biopharm, an innovative R&D-driven pharmaceutical group in China, to develop a…
Chemotherapy-TEVIMBRA Approved in U.S. for 1st-line Treatment of Gastric Cancers
BeiGene a global oncology Chemotherapy company that plans to rebrand itself as BeOne Medicines Ltd., has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of…
10 Clinical Research Excellence ICON and Employees Earn Prestigious Recognition
ICON plc a leading global healthcare intelligence and clinical research organization, has received multiple prestigious awards in the second half of 2024, further solidifying its position as a top performer…
Argenx Celebrates VYVDURA Approval in Japan for CIDP in Adults
Argenx SE a global immunology company dedicated to improving the lives of people affected by severe autoimmune diseases, has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has…
Colorectal Cancer Breakthrough Bristol Myers Squibb Secures EC Approval for Opdivo + Yervoy in MSI-High mCRC
Colorectal Cancer Breakthrough: Bristol Myers Squibb Secures EC Approval for Opdivo + Yervoy in MSI-High mCRC Bristol Myers Squibb has announced that the Colorectal Cancer European Commission (EC) has approved…
Bristol Myers Squibb Announces Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis
Bristol Myers Squibb has announced positive results from arthritis two pivotal Phase 3 trials, POETYK PsA-1 (IM011-054) and POETYK PsA-2 (IM011-055), which evaluated the efficacy and safety of Sotyktu (deucravacitinib)…
FDA Grants Groundbreaking Pioneering Approval for Opdivo Qvantig Injection in 5 Adult Solid Tumor Indications
Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted approval for Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection for subcutaneous use. This innovative combination product…
Lilly Applauds ITC Ruling on Counterfeit Tirzepatide Imports 2024
In a significant victory for patient safety, the judge presiding over Eli Lilly’s case before the International Trade Commission (ITC) ruled that U.S. Customs and Border Protection should block the…